473 related articles for article (PubMed ID: 33767709)
21. EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1.
Pan Y; Shu G; Fu L; Huang K; Zhou X; Gui C; Liu H; Jin X; Chen M; Li P; Cen J; Feng Z; Lu J; Chen Z; Li J; Xu Q; Wang Y; Liang H; Wang Z; Deng Q; Chen W; Luo J; Yang J; Zhang J; Wei J
Adv Sci (Weinh); 2023 Apr; 10(11):e2206792. PubMed ID: 36775874
[TBL] [Abstract][Full Text] [Related]
22. Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.
Carlo MI; Voss MH; Motzer RJ
Nat Rev Urol; 2016 Jul; 13(7):420-31. PubMed ID: 27324121
[TBL] [Abstract][Full Text] [Related]
23. IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
Rausch S; Kruck S; Stenzl A; Bedke J
Future Oncol; 2014 May; 10(6):937-48. PubMed ID: 24941980
[TBL] [Abstract][Full Text] [Related]
24. Importance of Multiparametric Evaluation of Immune-Related T-Cell Markers in Renal-Cell Carcinoma.
Kawashima A; Uemura M; Nonomura N
Clin Genitourin Cancer; 2019 Dec; 17(6):e1147-e1152. PubMed ID: 31473121
[TBL] [Abstract][Full Text] [Related]
25. Combination immunotherapy with interleukin-2 surface-modified tumor cell vaccine and programmed death receptor-1 blockade against renal cell carcinoma.
Zhang X; Shi X; Li J; Hu Z; Gao J; Wu S; Long Z
Cancer Sci; 2019 Jan; 110(1):31-39. PubMed ID: 30343514
[TBL] [Abstract][Full Text] [Related]
26. Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy.
Perego G; Barzaghi P; Vavassori I; Petrelli F
Med Oncol; 2020 Aug; 37(9):81. PubMed ID: 32767163
[TBL] [Abstract][Full Text] [Related]
27. Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma.
Clavijo-Salomon MA; Bergami-Santos PC; M Barbuto JA
Immunotherapy; 2017 Mar; 9(4):319-329. PubMed ID: 28303767
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy of metastatic renal cell cancer.
Fishman M; Seigne J
Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
[TBL] [Abstract][Full Text] [Related]
29. Current Landscape of Immunotherapy in Genitourinary Malignancies.
Alhalabi O; Rafei H; Bilen MA; Shah AY
Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
[TBL] [Abstract][Full Text] [Related]
30. Emerging immunotherapy in advanced renal cell carcinoma.
Mendiratta P; Rini BI; Ornstein MC
Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma.
Mollica V; Santoni M; Di Nunno V; Cimadamore A; Cheng L; Lopez-Beltran A; Battelli N; Montironi R; Massari F
Curr Drug Targets; 2020; 21(14):1463-1475. PubMed ID: 32160846
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
Anselmo Da Costa I; Rausch S; Kruck S; Todenhöfer T; Stenzl A; Bedke J
Expert Rev Anticancer Ther; 2017 Apr; 17(4):357-368. PubMed ID: 28162024
[TBL] [Abstract][Full Text] [Related]
33. [Immune anticancer response: recent advances in the treatment of renal cell carcinoma].
Bouet F; Catros V
Ann Biol Clin (Paris); 2004; 62(3):257-68. PubMed ID: 15217758
[TBL] [Abstract][Full Text] [Related]
34. Novel immunotherapeutic strategies in development for renal cell carcinoma.
Inman BA; Harrison MR; George DJ
Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
[TBL] [Abstract][Full Text] [Related]
35. Immune status and immune therapy of renal cell carcinoma.
Bichler KH; Kleinknecht S; Strohmaier WL
Urol Int; 1990; 45(5):269-83. PubMed ID: 2219564
[TBL] [Abstract][Full Text] [Related]
36. Combination immunotherapy in renal cell carcinoma.
Drake CG
Clin Adv Hematol Oncol; 2016 Feb; 14(2):99-100. PubMed ID: 27057808
[No Abstract] [Full Text] [Related]
37. Renal carcinoma (RC): regulation of antitumoral immune responses.
Heicappell R; Ackermann R
Prog Clin Biol Res; 1992; 378():207-16. PubMed ID: 1284503
[TBL] [Abstract][Full Text] [Related]
38. Renal cell cancer: is immunotherapy dead?
Wagstaff J
Ann Oncol; 2007 Jul; 18 Suppl 9():ix94-7. PubMed ID: 17631604
[No Abstract] [Full Text] [Related]
39. Immunotherapy for metastatic renal cell carcinoma.
McDermott DF; Rini BI
BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
[No Abstract] [Full Text] [Related]
40. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
Guida M; Colucci G
Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
